November 25, 2024 - 22:01

IceCure Medical Ltd. has announced that its next-generation multiprobe cryoablation technology has received a Notice of Allowance from Japan's Patent Office. This significant development marks a key milestone for the company's innovative approach to minimally invasive medical procedures.
The multiprobe cryoablation technology is designed to enhance the effectiveness and efficiency of cryoablation treatments, which are used to destroy abnormal tissues through extreme cold. This advancement is expected to provide physicians with improved tools for treating various medical conditions, potentially leading to better patient outcomes.
The approval from Japan's Patent Office underscores the technological advancements that IceCure is bringing to the field of cryoablation, positioning the company for growth in the competitive medical technology market.
November 20, 2025 - 03:50
Poland Emerges as a Leader in Artificial Intelligence InnovationIn the global landscape of technological advancement, Poland has quietly but decisively become one of the most dynamic centers for artificial intelligence (AI) innovation. Once perceived primarily...
November 19, 2025 - 12:10
Innovative Carbon Capture Technology EmergesMantel, a company established by a team of MIT alumni, has introduced a groundbreaking system designed to capture carbon dioxide emissions from factories and power plants. This innovative...
November 18, 2025 - 22:39
Diane Bryant Joins Jacobs' Board of DirectorsJacobs has officially welcomed Diane Bryant to its Board of Directors, with her appointment taking effect immediately. Bryant is a highly respected leader in the technology sector, bringing a...
November 18, 2025 - 08:31
Cassava Technologies Aims to Expand AI Access in Africa with Major InvestmentCassava Technologies, supported by Nvidia Corp., is set to raise up to $700 million to enhance and expand its network of data centers throughout Africa. This ambitious initiative focuses on...